Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Clinical trial NCT07553767 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07553767
- Sponsor
- Ningbo No.2 Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2034-12-31
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.